Tigecycline: Difference between revisions
From IDWiki
(Created page with "* Glycylcycline antibiotic * Related to tetracycline and doxycycline, with expanded coverage to include streptococci, Enterobacteriaceae, and Acinetobacter...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | ==Background== |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| + | |||
| + | ===Spectrum of Activity=== |
||
| + | |||
| ⚫ | |||
| + | *Does cover [[Acinetobacter]] and [[Stenotrophomonas]] |
||
| + | |||
| + | ===Pharmacokinetics and Pharmacodynamics=== |
||
| + | |||
| + | *Rapidly concentrates in tissue, but poor concentration in urine and lung tissue |
||
| + | |||
| + | ==Dosing== |
||
| + | |||
| + | *'''Intraabdominal infection:''' 100 mg IV load followed by 50 mg IV q12h |
||
| + | *'''Pneumonia:''' 100 mg IV load followed by 50 mg IV q12h |
||
| + | **High dosing may be useful in HAP/VAP with 100 mg IV q12h |
||
| + | *'''Skin and soft tissue infection:''' 100 mg IV load followed by 50 mg IV q12h |
||
| + | |||
| + | ==Safety== |
||
| + | |||
| + | *Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP |
||
| + | *Commonly causes nausea, vomiting, and diarrhea |
||
| + | *Also anemia, thrombocytopenia, hepatitis, jaundice, AKI |
||
| + | |||
| ⚫ | |||
Latest revision as of 08:56, 26 April 2021
Background
- Glycylcycline antibiotic
Spectrum of Activity
- Related to tetracycline and doxycycline, with expanded coverage to include streptococci and Enterobacteriaceae, but without coverage for unusual Gram-negative bacteria or Chlamydia trachomatis
- Does cover Acinetobacter and Stenotrophomonas
Pharmacokinetics and Pharmacodynamics
- Rapidly concentrates in tissue, but poor concentration in urine and lung tissue
Dosing
- Intraabdominal infection: 100 mg IV load followed by 50 mg IV q12h
- Pneumonia: 100 mg IV load followed by 50 mg IV q12h
- High dosing may be useful in HAP/VAP with 100 mg IV q12h
- Skin and soft tissue infection: 100 mg IV load followed by 50 mg IV q12h
Safety
- Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
- Commonly causes nausea, vomiting, and diarrhea
- Also anemia, thrombocytopenia, hepatitis, jaundice, AKI
